Robert B. Ford

Robert B. Ford is an American businessman. On 31 March 2020, he became the chief executive officer of Abbott Laboratories, a publicly-traded medical devices and health care company based in Abbott Park, Illinois.[2] Ford is Abbott's thirteenth CEO and was elected unanimously by the company's board.[3] He stated that the sale of medical devices such as FreeStyle Libre and diagnostics would be prioritized while CEO as well as developing technology to monitor consumer health through smartphones and other connected devices.[4] Ford joined Abbott in 1996 within its diabetes care business, later heading the company's medical device businesses, and Abbott's integration of St. Jude Medical in 2017, its largest acquisition at the time.[5][6] He was named President and COO in October 2018.[7]

Robert B. Ford
NationalityAmerican and Brazilian
EducationBoston College
University of California, Berkeley, Haas School of Business[1]
Years active1996-present

References
  1. Peter Loftus (13 November 2019). "Longtime Abbott Labs CEO Miles White to Step Down in March". The Wall Street Journal.
  2. Nick Williams (22 January 2020). "Abbott beats revenue projections as sales outperform previous year". Milwaukee Business Journal.
  3. "Abbott CEO Miles D White To Step Down In 2020, Robert B Ford To Take Over". Medical Dialogues. 15 December 2019.
  4. "Incoming Abbott CEO says not looking to do any deals". Reuters. 22 January 2020.
  5. Allison Gatlin (13 November 2019). "Medtech Giant Elects New CEO As 21-Year Veteran Steps Down". Investor's Business Daily.
  6. Robert Channick (13 November 2019). "Abbott CEO Miles White to step down in March". Chicago Tribune.
  7. Daniel Allar (15 October 2018). "Robert Ford named president, COO of Abbott". Cardiovascular Business.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.